Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $197.61 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $62.02 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $30.92 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $28.03 | 2 | $0 (2024) |
| Novo Nordisk Inc | $26.75 | 2 | $0 (2024) |
| Exact Sciences Corporation | $20.46 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.52 | 1 | $0 (2024) |
| ASSERTIO THERAPEUTICS, Inc. | $11.91 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.27 | 7 | GlaxoSmithKline, LLC. ($30.81) |
| 2023 | $51.67 | 3 | GlaxoSmithKline, LLC. ($31.21) |
| 2019 | $36.67 | 3 | Merck Sharp & Dohme Corporation ($13.13) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Obesity | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 09/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Oncology | ||||||
| 11/01/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: VACCINE | ||||||
| 05/09/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Obesity | ||||||
| 01/25/2019 | ASSERTIO THERAPEUTICS, Inc. | Gralise (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 835 | 1,104 | $257,854 | $59,800 |
| 2022 | 16 | 989 | 1,315 | $296,697 | $66,038 |
| 2021 | 13 | 846 | 1,168 | $265,249 | $69,446 |
| 2020 | 16 | 1,009 | 1,233 | $218,946 | $58,953 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 480 | $136,320 | $23,295 | 17.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $19,198 | $8,146 | 42.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 114 | 115 | $16,100 | $8,121 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 157 | $31,400 | $7,082 | 22.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 119 | 120 | $6,580 | $3,846 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $19,000 | $2,437 | 12.8% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 19 | 41 | $11,316 | $1,957 | 17.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 13 | 13 | $4,745 | $1,859 | 39.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,305 | $953.23 | 73.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $7,110 | $827.25 | 11.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 13 | $1,560 | $569.79 | 36.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 14 | $2,450 | $535.92 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $770.00 | $170.20 | 22.1% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 279 | 538 | $152,792 | $26,449 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 199 | $39,800 | $9,269 | 23.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 124 | 127 | $17,780 | $8,483 | 47.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $16,550 | $6,412 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 128 | 131 | $5,905 | $4,130 | 69.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $14,820 | $1,798 | 12.1% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 16 | 37 | $10,212 | $1,673 | 16.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 19 | $8,588 | $1,650 | 19.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 36 | 36 | $4,320 | $1,547 | 35.8% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 27 | 27 | $3,240 | $1,126 | 34.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 31 | 31 | $1,395 | $948.15 | 68.0% |
About Dr. Gary Shapiro, MD
Dr. Gary Shapiro, MD is a Family Medicine healthcare provider based in Mount Laurel, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386610228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Shapiro, MD has received a total of $197.61 in payments from pharmaceutical and medical device companies, with $109.27 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($197.61).
As a Medicare-enrolled provider, Shapiro has provided services to 3,679 Medicare beneficiaries, totaling 4,820 services with total Medicare billing of $254,237. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mount Laurel, NJ
- Active Since 02/28/2006
- Last Updated 10/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386610228
Products in Payments
- AREXVY (Drug) $31.21
- SHINGRIX (Biological) $30.81
- Cologuard Collection Kit (Device) $20.46
- LAGEVRIO (Drug) $17.79
- XIFAXAN (Drug) $17.52
- Wegovy (Drug) $15.12
- BREZTRI (Drug) $14.20
- FARXIGA (Drug) $13.83
- PNEUMOVAX 23 (Biological) $13.13
- Gralise (Drug) $11.91
- Saxenda (Drug) $11.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mount Laurel
Dr. Frank Pettinelli, D.o, D.O
Family Medicine — Payments: $1,394
Nicole Hancq, Md, MD
Family Medicine — Payments: $792.50
Dr. Frank Wilczynski, D.o, D.O
Family Medicine — Payments: $475.18
Dr. Randa Foda, M.d, M.D
Family Medicine — Payments: $329.07
Sophia Khan, M.d, M.D
Family Medicine — Payments: $295.52
Catherine Barone, D.o, D.O
Family Medicine — Payments: $84.88